How tirzepatide addresses cardiovascular risk The Jorge 2026 study demonstrated that GLP-1 receptor agonists were associated with significantly lower risks of major adverse cardiovascular events in lupus patients compared to DPP-4 inhibitors
Acta pharmacologica Sin (2021) 42(2):30110
The 5mg/mL concentration (typical of reconstituted lyophilized vials with 2mL BAC water) requires 200 units for a 10mg dose
FDA-approved medications are deemed safe for their intended use and works well for obtaining weight loss results
Andrew Hardaway, a professor of psychiatry and behavioral neurobiology at the University of Alabama at Birmingham, told Newsweek that case reports of "cosmetic abuse" of GLP-1s are already being recorded and are only just "catching up" with the issue
Options may include phentermine-topiramate, a combination medication that suppresses appetite, as well as medications originally approved for other conditions, such as the antidepressant bupropion (Wellbutrin) or the diabetes drug metformin
